International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen ReceptorsNick Z. Lu, John A. Cidlowski, Nancy L. Weigel et al.|Pharmacological Reviews|2006Cited by 430
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants MeetingJun Luo, Ganesh V. Raj, Richard J. Lee et al.|European Urology|2017Cited by 130
Nuclear Targeting of Cyclin-Dependent Kinase 2 Reveals Essential Roles of Cyclin-Dependent Kinase 2 Localization and Cyclin E in Vitamin D-Mediated Growth InhibitionOmar Flores, Kerry L. Burnstein|Endocrinology|2010Cited by 63
Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer CellsAnbalagan Jaganathan, Shiraz Mujtaba, Marc Philizaire et al.|Molecular Endocrinology|2014Cited by 34
Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityThirupandiyur S. Udayakumar, Alan Pollack, Radka Stoyanova et al.|Molecular Cancer Therapeutics|2016Cited by 20